logo-loader

Nemus Bioscience makes progress with cannabinoid-based glaucoma treatment

Published: 12:05 02 Oct 2018 EDT

Nemus Bioscience Inc (OTCMKTS:NMUS) had a chat with Christine Corrado from Proactive Investors at the MicroCap Conference in New York.

Nemus is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

35 minutes ago